Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,624,602
+$62,453,082 QoQ
Shares Held
2,405,640
+188.5% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#22
of 712 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Jun 30, 2025CallValue
$270,536
CallShares
5,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $847,064,370 across 13 Drug Manufacturers - General names. SNY ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
151,950 | $182,253,403 | |
| 2 | ABBV |
AbbVie Inc.
|
622,946 | $156,758,131 | |
| 3 | JNJ |
Johnson & Johnson
|
584,500 | $148,445,465 | |
| 4 | SNY |
Sanofi
This page
|
2,405,640 | $102,624,602 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
587,082 | $74,171,939 | |
| 6 | BIIB |
Biogen Inc.
|
265,090 | $57,275,345 | |
| 7 | NVO |
Novo Nordisk A S
|
1,109,982 | $53,212,537 | |
| 8 | OGN |
Organon & Co.
|
2,196,642 | $29,742,532 |
All Filings in SNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,624,602 | 2,405,640 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $40,171,520 | 833,780 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $22,846,499 | 484,036 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $270,536 | 5,600 | Call | Sole | 2025-08-14 | |
| 2024-12-31 | $3,428,863 | 71,094 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $38,712,894 | 671,749 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,804,492 | 861,593 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $6,550,186 | 131,715 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $21,046,063 | 390,465 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $8,269,180 | 170,745 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $12,591,800 | 260,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $43,342,800 | 1,140,000 | Call | Sole | 2022-11-15 | |
| 2022-09-30 | $11,555,038 | 303,920 | Shares | Sole | 2022-11-15 | |
| 2021-09-30 | $10,790,121 | 223,815 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $2,892,666 | 54,931 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,473,000 | 50,000 | Call | Sole | 2021-05-17 | |
| 2020-09-30 | $13,121,461 | 261,540 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $17,895,781 | 350,554 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $28,422,022 | 650,092 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||